SecBot SecBot
COURT-RULING ·Filed Sep 9, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed2mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This filing is a routine procedural order with no trading implications for MRK. Monitor the case for future substantive rulings on motions to dismiss, summary judgment, or trial.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$144.71
T+0 close · Sep 10, 2026 · via day close
Latest settled
−1.61%
T+20 · $142.38 · next T+60 in 17d
Vs SPY
−3.73%
α at T+20
Latest observation
+5.62%
T+45 · FF3 residual α
  1. T+0 · Sep 10 $144.71entry
  2. T+1 · 2mo ago −0.54%α −1.39% · $143.93
  3. T+5 · 2mo ago +1.69%α +1.06% · $147.15
  4. T+20 · 6w ago −1.61%α −3.73% · $142.38
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

This is a routine procedural order granting an attorney's application for pro hac vice admission in a case where Merck & Co., Inc. is a defendant. The order does not address any substantive legal issues, liability, damages, or injunctive relief. It has no financial or operational impact on Merck.

Court Ruling Details

Ruling Date
Sep 9, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Judge
William S. H. Orrick
Case Type
other
Ruling Type
procedural
Precedent Risk
LOW

Key Facts

  • The court granted an application for an out-of-state attorney to appear pro hac vice in the case Kaiser Foundation Health Plan Inc v. Merck & Company Inc. et al.
  • This is a purely administrative procedural order with no substantive ruling on the merits of the case.
  • No damages, injunctions, or financial exposure were addressed in this filing.

Financial Impact

No financial impact, the order is procedural only.

Risk Factors

  • No new risks identified from this filing.

Market Snapshot

Price
$144.62
Volume
199
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-a8a3257445-MRK

Track record

34 reports on MRK

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $147.76 Now $144.46 −2.23% settles Feb 11
  2. Nov 9, 20268d ago PTAB Trial Neutral 2/10 Entry $148.05 Now $144.46 −2.42% settles Feb 8
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  4. Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Entry $144.67 Now $144.46 +0.15% settles Feb 1
  5. Nov 2, 202614d ago 144 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 Now $144.46 −1.28% settles Jan 27
  7. Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 Now $144.46 −0.56% settles Jan 21
  8. Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $147.24 Now $144.46 −1.89% settles Jan 20
  9. Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
  10. Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (9h 39m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Sep 10, 2026